cardiomyocyte therapy (Cardion)

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug Namecardiomyocyte therapy (Cardion)
Drug Alias Namestem cell-derived cardiomyocytes (Cardion)stem cell therapy (Cardion)cardioprotectin
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Cardiac myocyte stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCardion
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCardion
Active IndicationsN/A
Inactive IndicationsMyocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A